GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs $50.88

down -2.34


23/7/2014 10:36 AM  |  NYSE : GSK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get GSK Trend Analysis - it has underperformed the S&P 500 by 14%

Partner Headlines

  1. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  2. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR ...

    Benzinga
  3. Morning Market Movers

    Benzinga
  4. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  5. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  6. British Stocks: Sweet Spot For European Value

    YCharts
  7. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  8. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  9. Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech ...

    Benzinga
  10. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  11. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies Considering ...

    Benzinga
  12. Major British Companies Lead Top Guru-Held UK and Ireland Stocks

    GuruFocus
  13. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  14. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  15. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  16. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  17. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  18. Can Pfizer Make Up Its Loss?

    GuruFocus
  19. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  20. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  21. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  22. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing GDP And ...

    Benzinga
  23. Glaxo hurt by Advair scandal

    IBD
  24. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  25. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  26. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  27. China Rule Change Further Opens Yuan To World Markets

    IBD
  28. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  29. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine for ...

    Benzinga
  30. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  31. Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical ...

    Benzinga
  32. Big Pharmas Swap Specialties

    IBD
  33. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  34. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  35. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  36. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  37. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  38. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  39. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  40. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  41. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  42. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  43. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  44. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  45. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  46. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  47. GlaxoSmithKline Finally Received Approval from FDA for Its Diabetes Drug ...

    GuruFocus
  48. Has A Streamlined FDA Raised The Value Of Drug Stocks?

    IBD
  49. Pharmaceutical Stocks For Income, Value, And Growth Investors

    Benzinga
  50. New Glaxo bribery inquiries

    IBD
Trading Center